Page last updated: 2024-10-25

decamethonium and Myotonic Dystrophy

decamethonium has been researched along with Myotonic Dystrophy in 1 studies

decamethonium: RN given refers to parent cpd
decamethonium : A quaternary ammonium ion that is a depolarising muscle relaxant whose structure comprises a decane-1,10-diamine core in which each amino group carries three methyl substituents.

Myotonic Dystrophy: Neuromuscular disorder characterized by PROGRESSIVE MUSCULAR ATROPHY; MYOTONIA, and various multisystem atrophies. Mild INTELLECTUAL DISABILITY may also occur. Abnormal TRINUCLEOTIDE REPEAT EXPANSION in the 3' UNTRANSLATED REGIONS of DMPK PROTEIN gene is associated with Myotonic Dystrophy 1. DNA REPEAT EXPANSION of zinc finger protein-9 gene intron is associated with Myotonic Dystrophy 2.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ORNDAHL, G1
STENBERG, K1

Other Studies

1 other study available for decamethonium and Myotonic Dystrophy

ArticleYear
Myotonic human musculature: stimulation with depolarizing agents. Mechanical registration of the effects of succinyldicholine, succinylmonocholine and decamethonium.
    Acta medica Scandinavica. Supplementum, 1962, Volume: 389

    Topics: Amyotrophic Lateral Sclerosis; Decamethonium Compounds; Humans; Muscular Atrophy; Muscular Dystrophi

1962